Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

In the United States, out-of-pocket (OOP) costs of brand-name medications for neurological disorders increased significantly ...

The Science of MS The year started with a report in Nature that detailed ... and there's often insufficient data available ...

Sen. Baldwin says opponent Hovde “opposes efforts to negotiate with the big pharmaceutical companies to lower the price of ...

A first healthy adults group has been dosed in an early clinical trial of an oral and myelin-protective treatment for all ...

(HealthDay News) — Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, for which costs continue to increase, according to a ...

People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...

Magee police arrested an Oklahoma man after officers said they found drugs during a traffic stop. The traffic stop occurred ...

A young Toowoomba mum has been accused of playing a larger role in an alleged drug syndicate operating in the region.

For millions of Americans, paying for the treatment needed to manage their diseases can become its own lifelong problem.

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, according to research led by Amanda Gusovsky, of Ohio State University ...